These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22285029)

  • 1. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients.
    Touré A; Lauverjat M; Peraldi C; Boncompain-Gerard M; Gelas P; Barnoud D; Chambrier C
    Clin Nutr; 2012 Aug; 31(4):567-70. PubMed ID: 22285029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP; Brind J; Tomar R; Hill S
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED; Rentenaar RJ; Rijs AJ; Wanten GJ
    Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
    J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED; Versleijen MW; Huisman-de Waal G; Feuth T; Kievit W; Wanten GJ
    PLoS One; 2014; 9(11):e111216. PubMed ID: 25379781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
    Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
    JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
    Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days.
    Cotogni P; Pittiruti M; Barbero C; Monge T; Palmo A; Boggio Bertinet D
    JPEN J Parenter Enteral Nutr; 2013; 37(3):375-83. PubMed ID: 23002096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study.
    John BK; Khan MA; Speerhas R; Rhoda K; Hamilton C; Dechicco R; Lopez R; Steiger E; Kirby DF
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):603-10. PubMed ID: 22205580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M; Pérez de Ciriza Cordeu M; Camblor Álvarez M; Bretón Lesmes I; Motilla de la Cámara M; Velasco Gimeno C; Arhip L; García Peris P; Cuerda Compés C
    Nutr Hosp; 2018 Jun; 35(4):761-766. PubMed ID: 30070861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections.
    Jurewitsch B; Jeejeebhoy KN
    Clin Nutr; 2005 Jun; 24(3):462-5. PubMed ID: 15896434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED; Nijland R; Gülich AF; Wanten GJ
    Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C; Poisson C; Talbotec C; Goulet O
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.